SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Groove Botanicals, Inc. (GRVE) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 14/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GRVE
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.01 |
$110.37K |
$100.31K |
90.9% |
| 2016 |
$-0.14 |
$52.93K |
$-2.5M |
-4730.2% |
| 2017 |
$-0.01 |
$57.02K |
$-234.78K |
-411.7% |
| 2019 |
$0.00 |
$16.39K |
$6.5K |
39.6% |
| 2020 |
$0.00 |
$5.03K |
$-5.19K |
-103% |
| 2021 |
$-0.01 |
$2.34K |
$-341.6K |
-14629.5% |
| 2022 |
$-0.01 |
$8.05K |
$-290.46K |
-3607.3% |
| 2023 |
$0.00 |
$1.18K |
$-120.73K |
-10231% |
| 2024 |
$-0.01 |
$0.00 |
$-202.09K |
- |
| 2025 |
$-0.01 |
$0.00 |
$-349.3K |
- |
